Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Front Immunol. 2023 Jul 13;14:1229516. doi: 10.3389/fimmu.2023.1229516. eCollection 2023.
The idea of psoriatic disease continuum has been progressively prompted based on the advances of the knowledge about the pathogenic steps underpinning the occurrence of psoriasis (PSO) and psoriatic arthritis (PSA). To evaluate biomolecules (inflammatory cytokines, inflammatory chemokines, cell adhesion and cellular mediators) in naïve patients with PSO, PSA with PSO, and PSA sine PSO. To stratify the results considering the presence of psoriatic nail involvement, extensive skin disease and obesity evaluating all involved patients.
By multiplex technology, 20 serum biomolecules were assessed with the inclusion of pro-inflammatory cytokines (GM-CSF, IFN-γ, IL-1α, IL-1β, IL-6, IL-8, IL-12p70, IL-17A, IL-23, TNF), anti-inflammatory cytokines (IFN-α, IL-4, IL-10, IL-13), inflammatory chemokines (IP-10, MCP-1, MIP-1α, MIP-1β), cell adhesion and cellular mediators (ICAM-1, E-selectin, P-selectin). The assessment of possible statistical differences between the means of the three groups was performed by One-Way ANOVA. In addition, by non-parametric T-tests, we stratified the results according to selected clinical characteristics (psoriatic nail involvement, PASI ≥ 10, BMI ≥ 30).
In 80 assessed naïve patients, patients with PSO showed significant increases of E-selectin (p=0.021) and IL-8 (0.041) than other groups. In patients with PSA with PSO, significant higher levels of ICAM-1 were observed (p=0.009) than other groups. We did not observe further differences comparing pro-inflammatory and anti-inflammatory cytokines, inflammatory chemokines, and cell adhesion and cellular mediators in patients with PSO, PSA with PSO, and PSA sine PSO. Patients with psoriatic onychopathy showed significant increased levels of ICAM-1 (p=0.010) and IP-10 (0.030) than others. In patients with PASI ≥ 10, significantly enhanced values of IL-8 (p=0.004), TNF (p=0.013), E-selectin (p=0.004), MIP-1α (p=0.003), and MIP-1β (p=0.039). In patients with BMI ≥ 30, significantly higher levels of E-selectin were pointed out (p=0.035) than others.
Our findings may suggest that a similar cytokine profile may characterize naïve patients with PSO, PSA with PSO, and PSA sine PSO, reinforcing the concept of psoriatic disease continuum. However, some differences may be also shown, underlying possible pathogenic differences and leading to the clinical heterogeneity of these patients.
基于对银屑病(PSO)和银屑病关节炎(PSA)发生的致病步骤的认识的进步,逐渐提出了银屑病疾病连续体的概念。评估初发银屑病患者、伴有银屑病的关节炎患者和无银屑病关节炎的银屑病患者的生物分子(炎症细胞因子、炎症趋化因子、细胞黏附分子和细胞介质)。考虑到存在银屑病甲受累、广泛皮肤疾病和肥胖,对所有受累患者进行分层。
通过多重技术,评估了 20 种血清生物分子,包括促炎细胞因子(GM-CSF、IFN-γ、IL-1α、IL-1β、IL-6、IL-8、IL-12p70、IL-17A、IL-23、TNF)、抗炎细胞因子(IFN-α、IL-4、IL-10、IL-13)、炎症趋化因子(IP-10、MCP-1、MIP-1α、MIP-1β)、细胞黏附分子和细胞介质(ICAM-1、E-选择素、P-选择素)。通过单因素方差分析(One-Way ANOVA)比较三组间均值的差异。此外,通过非参数 T 检验,根据选定的临床特征(银屑病甲受累、PASI≥10、BMI≥30)对结果进行分层。
在 80 名评估的初发患者中,与其他两组相比,银屑病患者的 E-选择素(p=0.021)和 IL-8(0.041)显著升高。在伴有银屑病关节炎的患者中,ICAM-1 水平显著升高(p=0.009)。与银屑病、伴有银屑病关节炎和无银屑病关节炎的患者相比,我们未观察到促炎和抗炎细胞因子、炎症趋化因子、细胞黏附分子和细胞介质的进一步差异。银屑病甲病患者的 ICAM-1(p=0.010)和 IP-10(p=0.030)水平显著升高。PASI≥10 的患者,IL-8(p=0.004)、TNF(p=0.013)、E-选择素(p=0.004)、MIP-1α(p=0.003)和 MIP-1β(p=0.039)水平显著升高。BMI≥30 的患者,E-选择素水平显著升高(p=0.035)。
我们的研究结果表明,初发银屑病患者、伴有银屑病关节炎的银屑病患者和无银屑病关节炎的银屑病患者可能具有相似的细胞因子谱,这进一步证实了银屑病疾病连续体的概念。然而,也可能存在一些差异,这可能表明存在潜在的发病机制差异,导致这些患者的临床异质性。